Oncothyreon Inc (USA)


Stock Update (NASDAQ:ONTY): Oncothyreon Inc (USA) Reports Full Year and Fourth Quarter 2015 Financial Results

Oncothyreon Inc (USA) (NASDAQ:ONTY), a clinical-stage biopharmaceutical company dedicated to the development of therapeutic products that can improve the lives and outcomes of patients …

Company Update (NASDAQ:ONTY): Oncothyreon Inc (USA) Announces First Patient Dosed in Randomized Phase 2 ONT-380 Combination Trial

Oncothyreon Inc (USA) (NASDAQ:ONTY), a clinical-stage biopharmaceutical company dedicated to the development of therapeutic products that can improve the lives and outcomes of patients …

Company Update (NASDAQ:ONTY): Oncothyreon Inc (USA) Appoints Christopher Henney, Ph.D., D.Sc. as Interim CEO and Expands Board With Additions of Mark Lampert and Gwen Fyfe, M.D.

Oncothyreon Inc (USA) (NASDAQ:ONTY), a clinical-stage biopharmaceutical company dedicated to the development of therapeutic products that can improve the lives and outcomes of patients …

Biotech Beat: Cantor Weighs In On Oncothyreon Inc (USA) (ONTY) and Galena Biopharma Inc (GALE)

Cantor analyst Mara Goldstein weighed in today on the cancer therapeutics company Oncothyreon Inc (USA) (NASDAQ:ONTY) and biotech company Galena Biopharma Inc (NASDAQ:GALE), with neutral ratings. The analyst …

Analysts Weigh In on Two Falling Stocks: Oncothyreon Inc (USA) (ONTY), Lululemon Athletica inc. (LULU)

Analysts weigh in on the biotech company Oncothyreon Inc (USA) (NASDAQ:ONTY) and yoga apparel giant Lululemon Athletica inc. (NASDAQ:LULU), as both stocks are suffering losses …

Company Update (NASDAQ:ONTY): Oncothyreon Inc (USA) to Present Updated Data on ONT-380 for the Treatment of HER2-Positive Breast Cancer at the San Antonio Breast Cancer Symposium

Oncothyreon Inc (USA) (NASDAQ:ONTY), a clinical-stage biopharmaceutical company dedicated to the development of oncology products that can improve the lives and outcomes of patients, …

Stock Update (NASDAQ:ONTY): Oncothyreon Inc (USA) Reports Third Quarter 2015 Financial Results

Oncothyreon Inc (USA) (NASDAQ:ONTY) reported financial results for the third quarter ended September 30, 2015. Net loss for the three months ended September 30, …

Company Update (NASDAQ:ONTY): Oncothyreon Inc (USA) Reports Second Quarter 2015 Financial Results

Oncothyreon Inc (USA) (NASDAQ:ONTY) reported financial results for the second quarter ended June 30, 2015. Net loss for the three months ended June 30, …

Biotech Beat: Oncothyreon Inc (USA), Innate Pharma SA, Regeneron Pharmaceuticals Inc and Merck & Co., Inc. News

Biotech has been in a funk for over a week now, though Friday finished strong. iShares’ NASDAQ Biotechnology ETF (IBB) has been stuck …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts